Who is sponsoring NCT06661785?

NCT06661785 is sponsored by Tanta University.

What drugs are being tested in NCT06661785?

Interventions in NCT06661785: large orbital floor fracture.

What condition does NCT06661785 study?

NCT06661785 studies Large Orbital Floor Fracture.

Is NCT06661785 still recruiting?

NCT06661785 is currently enrolling by invitation. Last updated 4 September 2025.

Last reviewed 2025-09-04 · How we verify

NCT06661785

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Interlocking Polyetheretherketone Implants for Orbital Floor Reconstruction

ENROLLING BY INVITATION NA Last updated 4 September 2025

What this trial tests

NA trial testing large orbital floor fracture in Large Orbital Floor Fracture in 22 participants. Enrolling by invitation.

Timeline

25 April 2024

Primary endpoint
25 July 2024

2 November 2025

Quick facts

Lead sponsor	Tanta University
Phase	NA
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	22
Start date	25 April 2024
Primary completion	25 July 2024
Estimated completion	2 November 2025
Sites	1 location across Egypt

Drugs / interventions tested

large orbital floor fracture

Conditions studied

Large Orbital Floor Fracture — all drugs for Large Orbital Floor Fracture →

Sponsor

Tanta University

Who can join

Adults 18 to 60, any sex, with Large Orbital Floor Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with large orbital floor fracture were reconstructed with interlocking polyetheretherketone patient-specific implant and will be evaluated clinically and radiographically

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06661785 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 4 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06661785.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing